SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (15)10/1/1999 9:43:00 AM
From: Edscharp   of 75
 
Opal,

I've never attended an FDA meeting and to be honest I'm not inclined to do so now. Aside from the fact that I'm incompetent to decipher the language of clinicians I question whether any hard information would be offered that would be helpful to investors in deciding whether a particular drug is worthy of approval.

Do they allow attendees unfettered access to phase III data? Will speakers openly discuss pharmaceuticals and the merits of heretofore unknown and unpublished information?

Now, if we could only attend that "closed" meeting......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News